Skip to content

Contango Silver & Gold CTGO Drawdown Of Silver Royalty

Drawdown Of Silver Royalty at other companies

Newmont logo
NewmontNEM
$572M-14.8%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$343.91M+3.7%
Royal Gold logo
Royal GoldRGLD
$73.01M+209%
Freeport-McMoRan Inc. logo
Freeport-McMoRan Inc.FCX
$278M+100%
Xencor logo
XencorXNCR
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$871.19M+75.2%

Other financials

Income statement

See full
Operating income$4.8M-75.0%
Net income-$14.3M+36.6%
EPS (diluted)-$0.83+55.9%

Balance sheet

See full
Cash & equivalents$97.5M+179%
Total debt$33.0M-41.2%
Total equity$321.5M+1,668%
Total assets$496.2M+237%

Cash flow

See full
Operating cash flow-$49.6M-274%
CapEx$150.5K
Free cash flow$23.3M+33.2%

Valuation

See full
Market cap$459.11M+81.8%
Enterprise value$394.63M+44.2%

Returns & leverage

See full
Return on equity-273.7%
Debt / equity0.1×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by Contango Silver & Gold in its filing.

Tagged under the XBRL concept ctgo:DrawdownOfSilverRoyalty.

The official record: Contango Silver & Gold ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Contango Silver & Gold 's drawdown of silver royalty.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Contango Silver & Gold 's drawdown of silver royalty?
Contango Silver & Gold (CTGO) reported drawdown of silver royalty of $339.26K in Q1 2026.
How has Contango Silver & Gold 's drawdown of silver royalty changed year-over-year?
Contango Silver & Gold 's drawdown of silver royalty increased by 199.9% year-over-year, from $113.12K to $339.26K.
What does drawdown of silver royalty mean?
This represents cash proceeds received from the monetization or drawdown of future silver production rights. It functions as a form of non-dilutive financing where the company receives upfront capital in exchange for a portion of future mineral output. This metric is essential for evaluating the company's alternative capital-raising strategies.